Cognition Hub
Multimodal AI in Biomarker Validation: Why Genomics Alone No Longer Cuts It
For decades, the genomic biomarker stood as the anchor of precision medicine. A single mutation, a variant call, a gene ...
Quality Over Quantity: How Intelligent Pre-qualification Transforms Clinical Trial Recruitment
Clinical trial sponsors invest millions in digital advertising campaigns each year, yet the majority of the leads those ...
Beyond Prostate Cancer: A Relook into Men's Genomic Health
Men's health has a measurement problem, and genomics is positioned to solve it. For decades, the conversation about ...
Cloud-native NGS: How 69% of High-throughput Labs Cut 30–60% Cost-per-sample
High-throughput clinical genomics has reached an inflection point, and the operational data now favors migration. ...
Building De-biased Genomic Datasets for Global Populations
Precision medicine promises treatments tailored to individual biology. That promise, however, rests on genomic data ...
Agentic AI: From Experiment to Execution in Clinical Trials
Clinical trial complexity is escalating on every measurable axis. Protocol design variables are trending upward across ...
Building AI-ready Multi-omics Data Lakes for Biomarker Discovery
Modern drug development generates staggering volumes of molecular data. Genomic repositories such as GenBank and the ...
How GenAI Is Changing Translational Research and Why It Matters Now
Translational research sits at the critical junction between laboratory discovery and clinical application. It is also ...
Women’s Health Trials, Faster: How Impactomics Helps Build Richer Recruitment Cohorts
Women’s health has become a high-priority topic in research and policy, but trial design still lags behind the need. ...
.jpg)
Why Agentic AI Is the Next Operating Layer for Bioinformatics Teams
Life sciences teams do not need another dashboard. They need a better way to move work. That is why agentic AI in life ...
Women’s Health Is Still Underserved by Modern Diagnostics and AI Can Help Change That!
Women’s health month should be more than a visibility moment. It should compel leaders to think about a harder ...
Laggard Clinical Trial Recruitment? Data-first Teams Can Fix It
Recruitment remains the weakest link in any clinical trial. For all the industry talk about digital transformation, ...
Building a CAP/CLIA-compliant NGS pipeline: A Technical Blueprint for Diagnostic Labs
In clinical genomics, the labs that scale fastest are not necessarily the ones with the most sophisticated sequencing ...
Multi-omics Explained: How Integrating Genomics, Proteomics, and Metabolomics Transforms Disease Understanding
When a cancer cell escapes therapy, it rarely relies on one rogue mutation. It rewires gene expression, shifts protein ...
What Is cfDNA? A Beginner’s Guide to Liquid Biopsy and Cell-free DNA Analysis
Imagine diagnosing cancer with a routine blood draw — no surgery, no tissue biopsy, and no weeks-long wait for a ...
The Trial Trap: How Recruitment Inertia is Killing Medical Innovation
"Every day a clinical trial stalls, somewhere a patient runs out of time waiting for a therapy that already exists in a ...
How Multi-omics, AI, and Real-world Evidence Are Accelerating Biomarker Discovery
"The right biomarker doesn’t just describe disease – it determines destiny." More data hasn’t solved biomarker ...
.jpg)
Bolstering Privacy, Trust, and Better Outcomes for Women With a HIPAA-compliant Platform
“Data without trust is noise.” When a woman walks into a clinic seeking answers about fertility, prenatal risk, or a ...
Designing Patient-centric Rare-disease Trials with AI, Digital Health, and Multi-omics
Peter Drucker, the renowned Austrian-American consultant and educator, famously said, “The best way to predict the ...
A CIO's Roadmap to Operationalizing Digital Health in India
India’s Ayushman Bharat Health Account (ABHA) and the National Digital Health Architecture are no longer experiments. ...
Omnichannel Patient Journey Orchestration: A Practical Playbook for Health Systems
As renowned U.S. pediatrician Don Berwick put it, "We are so fragmented, so broken apart in healthcare…” — a candid ...
From Sequencer to Tumor Board: How AI-powered Genomics Platforms Are Rewriting Cancer Diagnosis and Treatment
Cancer care is undergoing a profound shift. What once took weeks of manual interpretation between sequencing labs and ...
Audit-ready, Cloud-native NGS Pipelines: Ending the Rare Disease Diagnostic Odyssey with Reproducible Science
Did you know that an average rare disease patient spends nearly five years searching for a diagnosis—an odyssey of ...
Multi-omics Outside Oncology: Biomarker Discovery & Translational Pathways for Rare Diseases
The Lancet Health 2024 survey reports approximately 300 million patients with rare diseases worldwide, yet many of ...
AI-powered Germline Variant Interpretation: Transforming Rare Disease Diagnosis in the Era of Precision Medicine
For rare-disease patients, the diagnostic journey often stretches beyond six years and requires an average of 17 ...
Redefining Precision Diabetes Care: The ClairLabs Perspective
Diabetes care stands at a pivotal inflection point. After decades of relying on standardized, protocol-driven pathways, ...
.jpg)
How NGS and Machine Learning Are Driving 90%+ Diagnostic Performance in Lung Cancer
Global and national epidemiology shows lung cancer remains the leading cause of cancer mortality. Nearly 1.8 million ...
Beyond Treatment: Building AI-Driven Population Health Ecosystems
The healthcare’s next frontier is yet to witness a seismic shift, not by more treatments, but by fewer late-stage ...
Healthcare’s Deadliest Blind Spot: How Aggressive Digital Engagement Can Save Lives
Healthcare is in the midst of a revolution, with AI-powered diagnostics identifying diseases earlier than ever and ...
The Compliance Advantage: Building HIPAA-ready Genomics Infrastructure for Blood-cancer Breakthroughs
Cancer research has grown by leaps and bounds in recent years due to large-scale genomics projects, precision medicine ...
From Lab Bench to AI Agent: How Autonomous Systems Are Revolutionizing Blood Cancer Research
The global disease burden of Leukemia is set to escalate to 184,287.88 and 165,537.59, respectively, by 2040. Amid ...
From Silos to Seamless: How API-first Ecosystems Are Redefining Genomics & Healthcare IT
The success metrics for genomics and healthcare IT projects have undergone significant changes in the past few years. ...
Beyond Transcription: Why Your Next Health Assistant is an AI Agent
Beyond Transcription: Why Your Next Health Assistant is an AI Agent The relentless pace of scientific advancement ...
Multi-omics-led Tech Consulting in the Age of Generative Biology: Modernizing Labs for Building Foundation-scale Models
Looking back a decade ago, it’s amusing how we were all fascinated by J.A.R.V.I.S. in the movie Iron Man, an NLP-based ...
Reimagining Rare Disease Diagnosis with GenAI: ClairLabs’ Vision for the Future of Precision Medicine
Rare diseases account for nearly 5% of the global disease burden. With the advent of novel technologies such as AI, Gen ...
Cloud Cover: Uniting Multi-Site Trials for Men’s Wellness
Earlier, cloud-native technologies like microservices and containerization were limited to IT applications to enhance ...
Leveraging Real-World Evidence to Improve Men’s Health Outcomes
What if real-world data didn’t just inform, but rather transform men’s health — closing every gap from overlooked ...
AI-Driven Pharma Logistics: A Game Changer in Precision Medicine and Early Detection
AI is becoming an integral part of how early detection and personalized medicine are delivered across the care ...
Smart Inventory Management
Smart Inventory Management Smarter Stock, Faster Cures: The New Era of Smarter Inventory Management Is staying ahead ...
The Rise of Genomic Language Models
Let’s picture a scientist hunched over a mountain of DNA sequences, every base daunting, every code undeciphered. Enter ...
.jpg)
Accelerating the Future of Drug Discovery With AI
Picture this—A future where the blueprint for every breakthrough drug is mapped not in years but in moments, guided by ...
Quality Care for All: How Can AI Make Personalized Medicine More Accessible?
Waking up to a world where diseases are diagnosed with pinpoint accuracy, treatments tailored to your unique genetic ...
The Multi-omics Monetization Playbook
A Practical Charter for Leaders
The Clinical Genomics AI Readiness Checklist
Governance, Interpretation, and Cloud Infrastructure for Lab Leaders
Turn Genomic Complexity Into Clinical Clarity
Struggling with prolonged discovery cycles due to inaccurate genomic workflows? Discover how Impactomics uses AI, multi-omics, and cloud-native pipelines to accelerate genomic interpretation, reduce manual curation, and improve diagnostic confidence. Deliver AI-powered, decision-ready insights at scale.
Your DCTs and HCTs Deserve a Unified Operating Backbone
Struggling with site overload, fragmented DCT platform integration, and engagement drop-off in decentralized clinical trials? Discover how ClairLabs unifies e-recruitment, remote monitoring, local lab workflows, and regulated data pipelines into a single governed operating layer. Deliver audit-ready, scalable hybrid trial execution across every geography you operate in.
Turn Recruitment Bottlenecks into Enrollment Velocity
80–85% of clinical trials miss enrollment targets. Discover how a Unified AI Recruitment and Patient Engagement Control Tower compresses timelines, cuts screen failure rates in half, and lifts retention beyond 90%.
See How We Decoded the Future of Genomics at SIAMG 2025, Pune
At Pune, we promised to simplify complexity, and we did. Introducing Impactomics, our AI-genomics platform. Built on VarTk ML, labs now achieve...
AI Accelerating Clinical Trials in India
For decades, the progress of clinical trials worldwide has been hindered by prolonged timelines and excessive cost overruns that persist.
AI-powered Genomics: Future of Personalised Innovations in Healthcare
The article is authored by our Founder and CEO – Chandra Ambadipudi for Express Healthcare.
Lifesciences Industry Sees Significant Shifts With Digital Transformation & Increased M&As
The article is authored by our Founder and CEO – Chandra Ambadipudi for Pharmabiz.
9 Inspiring Women in the Field of Life Sciences
An initiative by TechEela in association with ClairLabs, celebrating women leaders throughout the year.
What if you could turn your raw data into renewable revenue?
Monetize FASTQ-to-insight pipelines: sell validated biomarker panels, data subscriptions, and co-development deals for a sustainable and elevated bottom line.
.png?width=287&height=386&name=Group%2048095782%20(4).png)
Partner with us to deploy Impactomics and unlock the full potential of your multi-omics data.